Stock MRK MERCK & CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse
Other stock markets
 21:00:02 31/05/2024 BST 		5-day change 1st Jan Change
125.5 USD +0.81% Intraday chart for Merck & Co., Inc. -3.05% +15.15%
05-31 Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival RE
05-31 Sector Update: Health Care MT

Chart calendar Merck & Co., Inc.

e.AMi4u8MuWzE8PhF4R3mfQP6KRRNWFAw0XkxMBF0Pj8k.evnRzpEDbQRQS04eIwPKGczwEisjIGEEKC4DbAJF_5t1jNCNoQNqVg1LQA~92f8cb85f617cbbc832fef8890219d30

Upcoming events on Merck & Co., Inc.

04/06/2024 00:00 American Society of Clinical Oncology Meeting
30/07/2024 11:30 Q2 2024 Earnings Release
30/07/2024 14:00 Q2 2024 Earnings Call
31/10/2024 10:30 Q3 2024 Earnings Release
31/10/2024 13:00 Q3 2024 Earnings Call
29/01/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)
04/08/2025 Q2 2025 Earnings Release (Projected)
22/10/2025 Q3 2025 Earnings Release (Projected)

Past events on Merck & Co., Inc.

30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 8012
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 9559
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 8502
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4093
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 5502
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: LBA4132
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4100
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4502
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 4045
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 9554
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: LBA9512
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No: 104
28/05/2024 14:00 Annual General Meeting
15/05/2024 21:40 BofA Securities Health Care Conference
25/04/2024 14:00 Q1 2024 Earnings Call
25/04/2024 11:30 Q1 2024 Earnings Release
13/03/2024 Ex-dividend day
12/03/2024 19:05 Barclays Global Healthcare Conference
11/03/2024 16:40 Leerink Partners Global Biopharma Conference
05/03/2024 18:30 TD Cowen Health Care Conference

Past dividends on Merck & Co., Inc.

13/03/2024 Quarterly 0.77 USD
13/12/2023 Quarterly 0.77 USD
13/09/2023 Quarterly 0.73 USD
13/06/2023 Quarterly 0.73 USD
13/03/2023 Quarterly 0.73 USD
13/12/2022 Quarterly 0.73 USD
13/09/2022 Quarterly 0.69 USD
13/06/2022 Quarterly 0.69 USD
13/03/2022 Quarterly 0.69 USD
13/12/2021 Quarterly 0.69 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		46 840
46 818
0.05%		47 994
48 177
-0.38%		48 704
48 367
0.7%		59 283
59 144
0.24%		60 115
59 938
0.3%
64 120

EBITDA
Million USD		Released
Forecast
Spread 		19 572
18 761
4.32%		20 570
19 815
3.81%		20 910
19 760
5.82%		26 431
24 588
7.5%		10 083
9 362
7.71%
29 228

EBIT
Million USD		Released
Forecast
Spread 		15 920
16 276
-2.19%		16 945
17 366
-2.43%		17 696
17 554
0.81%		22 522
22 363
0.71%		6 211
6 066
2.4%
26 193

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		11 464
12 277
-6.62%		8 791
14 906
-41.02%		13 879
12 048
15.2%		16 444
17 389
-5.44%		1 889
2 857
-33.89%
24 021

Net income
Million USD		Released
Forecast
Spread 		9 843
9 957
-1.15%		7 067
12 094
-41.57%		13 049
11 797
10.61%		14 519
14 827
-2.07%		365
1 682
-78.3%
19 507

EPS
USD		Released
Forecast
Spread 		3,81
3,83
-0.52%		2,78
4,71
-41%		5,14
4,70
9.39%		5,71
5,87
-2.73%		0,14
0,56
-75.16%
7,73

Announcement Date05/02/2004/02/2103/02/2202/02/2301/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		15 901
14 648
8.55%		14 593
13 861
5.28%		14 959
14 043
6.52%		13 830
13 676
1.12%		14 487
13 799
4.98%		15 035
14 450
4.05%		15 962
15 273
4.51%		14 630
14 480
1.03%		15 775
15 204
3.75%
15 822


16 665


15 958


16 565


17 490

EBITDA
Million USD		Released
Forecast
Spread 		7 568
5 918
27.88%		6 649
6 064
9.65%		6 516
6 275
3.85%		5 698
5 183
9.94%		5 402
5 058
6.8%		-3 485
-3 901
10.67%		7 538
6 724
12.1%		665
1 985
-66.49%		7 367
6 562
12.27%
7 364


8 236


7 613







EBIT
Million USD		Released
Forecast
Spread 		6 448
5 393
19.56%		5 711
5 157
10.75%		5 557
5 268
5.49%		4 806
4 592
4.66%		4 411
4 088
7.89%		-4 388
-4 683
6.29%		6 524
5 967
9.33%		-299
-476
37.23%		6 383
5 808
9.91%
6 504


7 018


6 279







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread





3 583
3 956
-9.43%		3 513
3 391
3.6%		3 650
4 190
-12.89%		-5 335
-4 682
-13.95%		5 620
5 023
11.89%		-2 046
-1 249
-63.78%		5 670
5 267
7.66%
6 044


6 461


5 750







Net income
Million USD		Released
Forecast
Spread 		4 310
3 768
14.4%		3 944
3 859
2.19%		3 248
3 477
-6.6%		3 017
3 016
0.02%		2 821
3 133
-9.97%		-5 975
-6 154
2.9%		4 745
4 224
12.34%		-1 226
-919
-33.43%		4 762
4 414
7.88%
4 955


5 443


4 814







EPS
USD		Released
Forecast
Spread 		1,70
1,48
14.96%		1,55
1,48
4.46%		1,28
1,42
-10.11%		1,18
1,20
-1.99%		1,11
1,21
-8.14%		-2,35
-2,44
3.61%		1,86
1,65
12.59%		-0,48
-0,35
-37.91%		1,87
1,79
4.45%
1,94


2,12


1,94







Announcement Date28/04/2228/07/2227/10/2202/02/2327/04/2301/08/2326/10/2301/02/2425/04/24-----

Upcoming sector events for Merck & Co., Inc.

03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release (Projected)
15/07/2024 JOHNSON & JOHNSON: Q2 2024 Earnings Release (Projected)
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
16/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Merck & Co., Inc.

30/05/2024 13:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00 FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 10:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
29/05/2024 09:44 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
29/05/2024 09:10 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
28/05/2024 PFIZER LIMITED: Q4 2024 Earnings Release
27/05/2024 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
27/05/2024 13:10 ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Calendar Merck & Co., Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW